DAIICHI SANKYO ESPHA
- Ranbaxy to shift focus from new drug research to genericsRanbaxy Laboratories has said it is shifting the focus of its research from the development of new drugs to that of generic drugs for effec...
- Daiichi sets up firm to market Ranbaxy products in JapanRanbaxy’s Japanese parent Daiichi Sankyo has set up a new firm, Daiichi Sankyo Espha Company (DSECL) for marketing generic drugs in Japan.
- Load More